Ezlopitant
Alternative Names: CJ 11974Latest Information Update: 19 Jul 2002
At a glance
- Originator Pfizer
- Class Antiemetics; Benzylamines; Heterocyclic bicyclo compounds
- Mechanism of Action Neurokinin 1 antagonists; Substance P inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
- Discontinued Nausea and vomiting
Most Recent Events
- 22 Jan 2001 Discontinued-III for Emesis in USA (Unknown route)
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 12 Apr 2000 CJ 11974 is now called ezlopitant (USAN)